Get the Stockscreener App
21.44
1.65%
-0.36
Innoviva Inc stock is traded at $21.44, with a volume of 1.26M.
It is down -1.65% in the last 24 hours and up +15.39% over the past month.
Innoviva Inc is a company with a portfolio of royalties healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Ellipta, Trelegy, Ellipta and others.
See More
Previous Close:
$21.80
Open:
$21.79
24h Volume:
1.26M
Relative Volume:
1.47
Market Cap:
$1.35B
Revenue:
$330.50M
Net Income/Loss:
$145.42M
P/E Ratio:
12.99
EPS:
1.65
Net Cash Flow:
$157.96M
1W Performance:
-0.42%
1M Performance:
+15.39%
6M Performance:
+16.71%
1Y Performance:
+32.67%
1-Day Range:
$21.24
$21.97
1-Week Range:
$21.22
$22.00
52-Week Range:
$15.70
$22.00
Innoviva Inc Stock (INVA) Company Profile
Name
Innoviva Inc
Sector
Industry
Phone
(650) 238-9600
Address
1350 OLD BAYSHORE HIGHWAY, BURLINGAME
Compare INVA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
INVA
Innoviva Inc
|
21.44 | 1.35B | 330.50M | 145.42M | 157.96M | 1.65 |
|
VRTX
Vertex Pharmaceuticals Inc
|
441.99 | 115.95B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
508.86 | 56.52B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
308.71 | 39.44B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
540.71 | 35.14B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
254.09 | 28.51B | 3.81B | -644.79M | -669.77M | -6.24 |
Innoviva Inc Stock (INVA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-07-25 | Initiated | Scotiabank | Sector Outperform |
| Jun-18-24 | Initiated | Cantor Fitzgerald | Overweight |
| Jul-20-22 | Initiated | Goldman | Neutral |
| Nov-20-17 | Initiated | Deutsche Bank | Hold |
Innoviva Inc Stock (INVA) Latest News
Rhumbline Advisers Sells 9,188 Shares of Innoviva, Inc. (NASDAQ:INVA) - Defense World
FDA Grants Priority Review for Innoviva's (INVA) Zoliflodacin | - GuruFocus
FDA Grants Priority Review for Zoliflodacin New Drug Application for the Treatment of Uncomplicated Gonorrhea and Assigns Target PDUFA Date of December 15, 2025 - Kalkine Media
FDA reviews new gonorrhea antibiotic from Innoviva By Investing.com - Investing.com South Africa
FDA Reviews Innoviva's (INVA) Zoliflodacin for Gonorrhea Treatment - GuruFocus
Innoviva Says FDA Accepts New Drug Application for Zoliflodacin - marketscreener.com
Innoviva Specialty's gonorrhea antibiotic to undergo FDA review (INVA) - Seeking Alpha
FDA reviews new gonorrhea antibiotic from Innoviva - Investing.com Australia
Innoviva Specialty Therapeutics Receives FDA New Drug Application Acceptance for Zoliflodacin, a First-in-Class Oral Antibiotic for Uncomplicated Gonorrhea in Adults - BioSpace
Innoviva (INVA) Awaits FDA Decision on New Gonorrhea Antibiotic | INVA Stock News - GuruFocus
Transcript : Innoviva, Inc. Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-09-2025 01 - marketscreener.com
Innoviva: A Riddle Wrapped In A Mystery Inside An Enigma (NASDAQ:INVA) - Seeking Alpha
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Boosts Holdings in Innoviva, Inc. (NASDAQ:INVA) - Defense World
INVA stock touches 52-week high at $21.35 amid robust gains - Investing.com Nigeria
Innoviva to Participate in Upcoming Investor Conferences - BioSpace
(INVA) Technical Pivots with Risk Controls - news.stocktradersdaily.com
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Has $546,000 Holdings in Innoviva, Inc. (NASDAQ:INVA) - Defense World
Ameriprise Financial Inc. Has $2.50 Million Holdings in Innoviva, Inc. (NASDAQ:INVA) - Defense World
Innoviva, Inc. (NASDAQ:INVA) Stock Holdings Lifted by Millennium Management LLC - Defense World
(INVA) Proactive Strategies - news.stocktradersdaily.com
Innoviva Elects Board Members and Approves Compensation - TipRanks
Bank of America Corp DE Decreases Holdings in Innoviva, Inc. (NASDAQ:INVA) - Defense World
ZEVTERA® (ceftobiprole), an Advanced-Generation Cephalosporin Antibiotic Now Commercially Available in the U.S. to Treat Three Types of Bacterial Infections - BioSpace
Innoviva (INVA) Launches New Antibiotic ZEVTERA for MRSA Treatme - GuruFocus
ZEVTERA(Ceftobiprole), An Advanced-Generation Cephalosporin Antibiotic Now Commercially Available In The U.S. To Treat Three Types Of Bacterial Infections - marketscreener.com
Basilea announces commercial availability of antibiotic Zevtera® (ceftobiprole) in the United States - The Manila Times
Cubist Systematic Strategies LLC Makes New $184,000 Investment in Innoviva, Inc. (NASDAQ:INVA) - Defense World
Innoviva, Inc. (NASDAQ:INVA) Shares Bought by Northern Trust Corp - Defense World
Comerica Bank Sells 141,150 Shares of Innoviva, Inc. (NASDAQ:INVA) - Defense World
Armata Completes Crucial Bacteriophage Trial, Lands $4.65M Defense Contract Amid Strong Q1 Results - Stock Titan
(INVA) Investment Analysis - news.stocktradersdaily.com
Investor Network: Innoviva, Inc. to Host Earnings Call - ACCESS Newswire
Envestnet Asset Management Inc. Has $258,000 Stock Position in Innoviva, Inc. (NASDAQ:INVA) - Defense World
Innoviva, Inc. (INVA): Among Stocks with Insanely High PE Ratios Insiders Are Selling - Insider Monkey
Innoviva Reports First Quarter 2025 Financial Results; Highlights Recent Company Progress - BioSpace
Innoviva: Q1 Earnings Snapshot - MySA
Innoviva Inc reports results for the quarter ended March 31Earnings Summary - TradingView
INVA Posts Strong Q1 Results with Revenue Growth and Strategic Developments | INVA Stock News - GuruFocus
BlackRock, Inc. Reduces Stake in Innoviva Inc: A Detailed Analysis - GuruFocus
Wells Fargo & Company MN Purchases 10,637 Shares of Innoviva, Inc. (NASDAQ:INVA) - Defense World
Trading (INVA) With Integrated Risk Controls - news.stocktradersdaily.com
Innoviva (NASDAQ:INVA) Stock Rating Upgraded by StockNews.com - Defense World
Rep. George Whitesides Unloads Shares of Innoviva, Inc. (NASDAQ:INVA) - Defense World
Rep. George Whitesides Sells Off Shares of Innoviva, Inc. (NASDAQ:INVA) - Defense World
Innoviva Inc Stock (INVA) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.63%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):